Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SPARCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LIPF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01004 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TSGA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY86-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT3H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00703 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929406 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIQK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on